Literature DB >> 18235898

Conjunctival changes induced by prostaglandin analogues and timolol maleate: a histomorphometric study.

Heloisa Helena Abil Russ1, Vital Paulino Costa, Fabiano Montiani Ferreira, Sílvia Regina Valgas, Mario Adolfo Correa Neto, Eduardo von Linsingen Strobel, Jessé Henrique Truppel.   

Abstract

PURPOSE: To compare histological changes induced by antiglaucoma medications in the rabbit conjunctiva.
METHODS: Fifty New Zealand rabbits were divided in 5 groups of 10 animals. The left eyes were treated daily with one drop of bimatoprost 0.03%, travoprost 0.004%, latanoprost 0.005%, timolol maleate 0.5% or artificial tears containing benzalkonium chloride (BAK) for 30 days. The right eyes served as controls. Superior limbic conjunctival biopsies were performed at the 8th and 30th day in 5 rabbits of each group. The conjunctiva was fixed with 10% formaldehyde, followed by HE and PAS staining. Morphohistometric quantitative analyses were performed to evaluate the following parameters: inflammatory infiltrate, epithelial thickness, number of goblet cells, diameter and number of blood vessels.
RESULTS: At the 8th and 30th posttreatment days, all groups, except one that received artificial tears, exhibited a diffuse inflammatory infiltrate, composed by lymphocytes and neutrophils, which was denser in the timolol group than in the prostaglandin (PG) analogues groups. At the 30th day, the timolol group also showed an increased subepithelial collagen density and a significant increase in epithelial thickness (p=0.0035). The goblet cell density was significantly increased at the 8th day in the group treated with travoprost (p=0.0006), and at the 30th day in those treated with bimatoprost (p=0.0021) and latanoprost (p=0.009).
CONCLUSIONS: Although a moderate, diffuse inflammatory infiltrate was observed in PG-treated eyes, no changes in conjunctival epithelial thickness or subconjunctival collagen density were observed with these medications, suggesting that these drugs induce fewer changes than timolol maleate in the rabbit conjunctiva.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18235898     DOI: 10.1590/s0004-27492007000600005

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  8 in total

1.  Exfoliating goblet cell hyperplasia mimicking pterygium: a clinicopathological case report.

Authors:  Anne E Barañano; Daniel V Vasconcelos-Santos; Narsing A Rao
Journal:  Int Ophthalmol       Date:  2010-01-03       Impact factor: 2.031

2.  In Vivo Scanning Laser Confocal Microscopy of Conjunctival Goblet Cells in Medically-controlled Glaucoma.

Authors:  Silvio DI Staso; Luca Agnifili; Marco Ciancaglini; Gianluca Murano; Enrico Borrelli; Leonardo Mastropasqua
Journal:  In Vivo       Date:  2018 Mar-Apr       Impact factor: 2.155

Review 3.  In Vivo Analysis of Prostaglandins-induced Ocular Surface and Periocular Adnexa Modifications in Patients with Glaucoma.

Authors:  Silvio DI Staso; Luca Agnifili; Sara Cecannecchia; Angela DI Gregorio; Marco Ciancaglini
Journal:  In Vivo       Date:  2018 Mar-Apr       Impact factor: 2.155

4.  A randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprost.

Authors:  E Randy Craven; Ching-Chi Liu; Amy Batoosingh; Rhett M Schiffman; Scott M Whitcup
Journal:  Clin Ophthalmol       Date:  2010-12-06

Review 5.  A Narrative Review of Ocular Surface Disease Related to Anti-Glaucomatous Medications.

Authors:  Xiaoyu Zhou; Xinyue Zhang; Dengming Zhou; Yang Zhao; Xuanchu Duan
Journal:  Ophthalmol Ther       Date:  2022-08-09

6.  Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides.

Authors:  Scott D Smid
Journal:  Clin Ophthalmol       Date:  2009-12-29

7.  Conjunctival changes and inflammatory aspects in rabbits' conjunctivas induced by fixed combinations of prostaglandin analogues and timolol maleate.

Authors:  Nubia Vanessa Lima de Faria; Heloisa Helena Russ; Palloma Rose; Lucia Noronha; Paulo Augusto Mello; Fabiano Montiani-Ferreira; Sebastião Cronemberger Sobrinho
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-01-28

8.  Ocular surface evaluation in patients treated with a fixed combination of prostaglandin analogues with 0.5% timolol maleate topical monotherapy: a randomized clinical trial.

Authors:  Heloisa Helena Russ; Pedro Antônio Nogueira-Filho; Jeison de Nadai Barros; Nubia Vanessa Lima de Faria; Fabiano Montiani-Ferreira; José Álvaro Pereira Gomes; Paulo Augusto Arruda Mello
Journal:  Clinics (Sao Paulo)       Date:  2013-10       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.